Commitments and Contingencies - Additional Information (Detail) - USD ($) |
1 Months Ended | 3 Months Ended |
---|---|---|
Jan. 31, 2020 |
Mar. 31, 2020 |
|
Loss Contingencies [Line Items] | ||
Indemnification liability recorded during the period | $ 0 | |
Teoxane Agreement | ||
Loss Contingencies [Line Items] | ||
Collaborative agreement, contractual period | 10 years | 10 years |
Collaborative agreement, extended contractual period | 2 years | 2 years |
Fair value of assets acquired | $ 43,500,000 | |
List Laboratories | Product Approval Payment Derivative | ||
Loss Contingencies [Line Items] | ||
Accrued milestone obligations | $ 2,000,000.0 | |
Botulinum Toxin Research Associates, Inc. | ||
Loss Contingencies [Line Items] | ||
Accrued milestone obligations | 16,000,000.0 | |
BioSentinel, Inc. | ||
Loss Contingencies [Line Items] | ||
Accrued milestone obligations | 300,000 | |
Other Current Liabilities | ||
Loss Contingencies [Line Items] | ||
Fair value of assets acquired | $ 1,000,000.0 |